208 related articles for article (PubMed ID: 11292019)
41. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
[TBL] [Abstract][Full Text] [Related]
42. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice.
Malaviya R; Ross E; Jakschik BA; Abraham SN
J Clin Invest; 1994 Apr; 93(4):1645-53. PubMed ID: 7512987
[TBL] [Abstract][Full Text] [Related]
43. SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations.
Huber M; Gibbs BF
Mol Immunol; 2015 Jan; 63(1):32-7. PubMed ID: 24679713
[TBL] [Abstract][Full Text] [Related]
44. The importance of leukotrienes in mast cell-mediated Toxoplasma gondii cytotoxicity.
Henderson WR; Chi EY
J Infect Dis; 1998 May; 177(5):1437-43. PubMed ID: 9593043
[TBL] [Abstract][Full Text] [Related]
45. Selective activation of human intestinal mast cells by Escherichia coli hemolysin.
Krämer S; Sellge G; Lorentz A; Krueger D; Schemann M; Feilhauer K; Gunzer F; Bischoff SC
J Immunol; 2008 Jul; 181(2):1438-45. PubMed ID: 18606698
[TBL] [Abstract][Full Text] [Related]
46. Down-modulation of antigen-induced activation of murine cultured mast cells sensitized with a highly cytokinergic IgE clone.
Sakanaka M; Kurimune Y; Yamada K; Hyodo N; Natsuhara M; Ichikawa A; Furuta K; Tanaka S
Immunol Lett; 2016 Jun; 174():1-8. PubMed ID: 27060497
[TBL] [Abstract][Full Text] [Related]
47. Mast cells in inflammatory arthritis.
Nigrovic PA; Lee DM
Arthritis Res Ther; 2005; 7(1):1-11. PubMed ID: 15642148
[TBL] [Abstract][Full Text] [Related]
48. Mast cells as effector cells of innate immunity and regulators of adaptive immunity.
Cardamone C; Parente R; Feo GD; Triggiani M
Immunol Lett; 2016 Oct; 178():10-4. PubMed ID: 27393494
[TBL] [Abstract][Full Text] [Related]
49. Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming.
Brzezińska-Błaszczyk E; Rdzany RS
Immunol Lett; 2007 Apr; 109(2):138-44. PubMed ID: 17350692
[TBL] [Abstract][Full Text] [Related]
50. Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.
Elieh Ali Komi D; Bjermer L
Clin Rev Allergy Immunol; 2019 Apr; 56(2):234-247. PubMed ID: 30506113
[TBL] [Abstract][Full Text] [Related]
51. Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation.
Tkaczyk C; Viguier M; Boutin Y; Frandji P; David B; Hébert J; Mécheri S
Immunology; 1998 Jul; 94(3):318-24. PubMed ID: 9767412
[TBL] [Abstract][Full Text] [Related]
52. Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis.
Shin JS; Shelburne CP; Jin C; LeFurgey EA; Abraham SN
J Immunol; 2006 Nov; 177(9):5791-800. PubMed ID: 17056503
[TBL] [Abstract][Full Text] [Related]
53. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli.
Malaviya R; Ikeda T; Abraham SN; Malaviya R
Immunol Lett; 2004 Feb; 91(2-3):103-11. PubMed ID: 15019277
[TBL] [Abstract][Full Text] [Related]
54. Vigna angularis inhibits mast cell-mediated allergic inflammation.
Kim HH; Kim SW; Kim DS; Oh HM; Rho MC; Kim SH
Int J Mol Med; 2013 Sep; 32(3):736-42. PubMed ID: 23828310
[TBL] [Abstract][Full Text] [Related]
55. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
[TBL] [Abstract][Full Text] [Related]
56. The role of mast cells in host defense and their subversion by bacterial pathogens.
Féger F; Varadaradjalou S; Gao Z; Abraham SN; Arock M
Trends Immunol; 2002 Mar; 23(3):151-8. PubMed ID: 11864844
[TBL] [Abstract][Full Text] [Related]
57. Clinical implications of mast cell-bacteria interaction.
Malaviya R; Abraham SN
J Mol Med (Berl); 1998 Aug; 76(9):617-23. PubMed ID: 9725764
[TBL] [Abstract][Full Text] [Related]
58. Signaling through Toll-like receptor 4 and mast cell-dependent innate immunity responses.
Avila M; Gonzalez-Espinosa C
IUBMB Life; 2011 Oct; 63(10):873-80. PubMed ID: 21905201
[TBL] [Abstract][Full Text] [Related]
59. Activated mast cells produce interleukin 13.
Burd PR; Thompson WC; Max EE; Mills FC
J Exp Med; 1995 Apr; 181(4):1373-80. PubMed ID: 7535336
[TBL] [Abstract][Full Text] [Related]
60. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI.
Okayama Y; Hagaman DD; Metcalfe DD
J Immunol; 2001 Apr; 166(7):4705-12. PubMed ID: 11254731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
